FutureFuel (FF) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
Q2 2024 net income was $9.6M ($0.22/share), reversing a $9.9M loss in Q2 2023; adjusted EBITDA was $6.9M, up from negative $7.3M, driven by improved gross profit and a legal settlement.
Revenue for Q2 2024 was $72.4M, down 15% year-over-year, mainly due to lower biofuel sales volumes and prices.
Six-month 2024 net income rose 24% to $13.9M ($0.32/share), and adjusted EBITDA increased 63% to $14.0M.
Financial highlights
Q2 2024 gross profit was $8.7M, reversing a $8.6M loss in Q2 2023; six-month gross profit rose to $13.7M.
Q2 2024 income from operations was $5.5M vs. a loss of $11.6M in Q2 2023; six-month operating income was $7.6M, up 15%.
Q2 2024 EPS was $0.22 (basic and diluted), up from a loss of $0.23 per share in Q2 2023; six-month EPS was $0.32, up from $0.26.
Cash and cash equivalents at June 30, 2024 were $115.1M, down from $219.4M at year-end 2023, mainly due to a special dividend.
Capital expenditures for the first six months were $5.3M, up from $3.9M year-over-year.
Outlook and guidance
Management expects existing cash, operating cash flow, and credit facility to be sufficient for foreseeable operations, development, and dividends.
Management notes a recovering chemical industry and a competitive biofuels market, with ongoing margin pressure from low biodiesel and RIN prices.
Future quarterly dividends of $0.06/share are scheduled for September and December 2024.
No material changes to risk factors or forward-looking statements since the last annual report.
Latest events from FutureFuel
- 2025 saw steep losses and revenue declines, but new plant investments and regulatory clarity support a 2026 rebound.FF
Q4 202516 Mar 2026 - Annual meeting to elect directors, ratify auditor, and update governance and compensation.FF
Proxy Filing2 Dec 2025 - Shareholders will elect directors, ratify a new auditor, and see board and leadership changes.FF
Proxy Filing2 Dec 2025 - Q3 2025 revenue dropped 56% with a $9.3M net loss amid biofuel market and regulatory headwinds.FF
Q3 202510 Nov 2025 - Q2 2025 revenue fell 51% and net loss reached $10.4M as biodiesel production was idled.FF
Q2 202511 Aug 2025 - Q3 loss and cash decline driven by biofuel weakness, margin pressure, and special dividend.FF
Q3 202413 Jun 2025 - Revenue fell 70% and net loss hit $17.6M amid operational and regulatory challenges.FF
Q1 20256 Jun 2025 - 2024 saw steep profit declines from biofuel headwinds, but chemicals showed resilience.FF
Q4 20245 Jun 2025